VolitionRx Limited Schedules Second Quarter 2019 Earnings Conference Call and Business Update
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock
VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding
VolitionRx Limited Announces First Quarter 2019 Financial Results and Business Update
VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer
VolitionRx Limited Schedules First Quarter 2019 Earnings Conference Call and Business Update
VolitionRx Limited Hosts Capital Markets Day at the New York Stock Exchange and Issues Company Update Report
VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics
VolitionRx Limited Extends Clinical Trial Program in Lung Cancer
